Commission Delegated Regulation (EU) 2026/1451 amending Regulation (EU) 2017/745 on medical devices enters into force on 19 July 2026, expanding requirements for implantable and Class III devices.
Latvia ZVA (State Agency of Medicines) · LatviaCTIS safety module launches 28 September 2026 for annual safety report (ASR) submission by clinical trial sponsors.
Latvia ZVA (State Agency of Medicines) · LatviaCommission Delegated Regulation (EU) 2026/314 entered into force on 18 May 2026, amending the classification of specific synthetic cathinone and amphetamine precursors.
Latvia ZVA (State Agency of Medicines) · LatviaEMA published guidance and template for pharmaceutical companies to develop shortage prevention plans (SPP) for medicines.
Latvia ZVA (State Agency of Medicines) · LatviaFrom 1 July 2026, the CMDh has abolished the requirement to submit cover letters for Type IA variations to medicinal products.
Latvia ZVA (State Agency of Medicines) · LatviaLatvia's State Agency of Medicines enhanced the Medicine Register to display pharmacy availability with a green checkmark indicator.
Latvia ZVA (State Agency of Medicines) · LatviaLatvia ZVA opens registration for four remaining DCP procedure slots in 2027 (January, July) with Latvia as reference member state.
Latvia ZVA (State Agency of Medicines) · LatviaThe State Agency of Medicines requests pharmacies to report temporary operational disruptions including power, internet or other service failures.
Latvia ZVA (State Agency of Medicines) · LatviaPharmacy operations in Latvia have largely resumed and are operating normally following storm damage, according to reports from the Latvian Pharmacists Association.
Latvia ZVA (State Agency of Medicines) · LatviaLatvia's State Agency of Medicines has developed an online form to reduce administrative burden for pharmacies and wholesalers reporting operating hours changes.
Latvia ZVA (State Agency of Medicines) · LatviaStorm damage and power outages may cause temporary service disruptions or changes to operating hours at some pharmacies.
Latvia ZVA (State Agency of Medicines) · LatviaPlanned technical maintenance of the State Agency of Medicines website may cause temporary disruptions for some users in the coming days.
Latvia ZVA (State Agency of Medicines) · LatviaNew safety information identified for desogestrel and etonogestrel contraceptives and for Litfulo (alopecia treatment).
Latvia ZVA (State Agency of Medicines) · LatviaLatvia ZVA opens booking for free time slots for medicine registration applications under DCP procedures and national procedures for 2027.
Latvia ZVA (State Agency of Medicines) · Latvia07.07.2026. Zāļu pieejamība, drošuma uzraudzība un jaunu ārstēšanas iespēju attīstība Latvijā bija Zāļu valsts aģentūras (ZVA) galvenās prioritātes 2025. gadā. Aizvadītajā gadā ZVA ne tikai uzraudzīja zāļu cenu reform...
Latvia ZVA (State Agency of Medicines) · LatviaPRAC concludes evidence on neurodevelopmental risk in children of fathers treated with valproates is conflicting; recommends updating product information.
Latvia ZVA (State Agency of Medicines) · LatviaSafety communication on meningioma risk associated with desogestrel and etonogestrel-containing contraceptive medicines and recommended risk-mitigation actions.
Latvia ZVA (State Agency of Medicines) · LatviaPfizer issued updated safety recommendations for Litfulo (ritlecitinib) to reduce risks of malignancy, cardiovascular events, infections, thromboembolism and death.
Latvia ZVA (State Agency of Medicines) · LatviaEMA's PRAC committee has begun assessment of iron-containing injectable medicines regarding low blood phosphate levels and bone effects.
Latvia ZVA (State Agency of Medicines) · LatviaNew liver injury risk identified for Ocrevus (ocrelizumab); liver function monitoring recommended before and during treatment.
Latvia ZVA (State Agency of Medicines) · LatviaRoche notified healthcare professionals of possible insoluble foreign particles in prepared Evrysdi oral solution in certain batches.
Latvia ZVA (State Agency of Medicines) · LatviaEMA's CHMP has completed review of Tavneos (avacopan) and recommended withdrawal of its marketing authorisation and discontinuation of distribution in the EU.
Latvia ZVA (State Agency of Medicines) · LatviaNovo Nordisk Latvia announces discontinuation of Protaphane FlexPen and Levemir insulin products.
Latvia ZVA (State Agency of Medicines) · Latvia